Skip to main content

2021 Editor's highlights

2021 has been a very successful year for Cardiovascular Diabetology: besides gaining an Impact Factor of 9.951, the journal has received as many submissions as never before. As the journal has published over 200 publications, we would like to offer you a selection of this year’s highlight articles. 
While COVID has still been an important topic in Cardiovascular Diabetology this year, we also observed a special interest of researchers in issues related to gender differences and their impact on clinics and biochemical parameters (three of the thirteen selected articles are connected to this topic), as well as in coagulation and fibrinolysis, heart failure, low grade inflammation, epicardial adipose tissue, autonomic dysregulation, biomarkers' diagnostic and prognostic value.

Persistent clotting protein pathology in Long COVID/Post-Acute Sequelae of COVID-19 (PASC) is accompanied by increased levels of antiplasmin
Etheresia Pretorius, Mare Vlok, Chantelle Venter, Johannes A. Bezuidenhout, Gert Jacobus Laubscher, Janami Steenkamp & Douglas B. Kell
Original investigation  |   Published: 23 August 2021

Low-grade inflammation as a risk factor for cardiovascular events and all-cause mortality in patients with type 2 diabetes
Shahnam Sharif, Y. Van der Graaf, M. J. Cramer, L. J. Kapelle, G. J. de Borst, Frank L. J. Visseren, Jan Westerink on behalf of the SMART study group
Original investigation  |  Published: 09 November 2021

Heart failure in type 2 diabetes: current perspectives on screening, diagnosis and management
Antonio Ceriello, Doina Catrinoiu, Chanchal Chandramouli, Francesco Cosentino, Annique Cornelia Dombrowsky, Baruch Itzhak, Nebojsa Malić Lalic, Francesco Prattichizzo, Oliver Schnell, Petar M. Seferović, Paul Valensi, Eberhard Standl on behalf of the D&CVD EASD Study Group
Review  |   Published: 06 November 2021

Autonomic nervous system activity changes in patients with hypertension and overweight: role and therapeutic implications
Paul Valensi
Review  |    Published: 19 August 2021

Association of sex-specific differences in lipoprotein(a) concentrations with cardiovascular mortality in individuals with type 2 diabetes mellitus
Marcello Ricardo Paulista Markus, Till Ittermann, Sabine Schipf, Martin Bahls, Matthias Nauck, Henry Völzke, Raul Dias Santos, Annette Peters, Tanja Zeller, Stephan Burkhard Felix, Ramachandran S. Vasan, Barbara Thorand, Elisabeth Steinhagen-Thiessen & Marcus Dörr
Original investigation  |  Published: 18 August 2021

CAPTURE: a multinational, cross-sectional study of cardiovascular disease prevalence in adults with type 2 diabetes across 13 countries
Ofri Mosenzon, Abdullah Alguwaihes, Jose Luis Arenas Leon, Fahri Bayram, Patrice Darmon, Timothy M. E. Davis, Guillermo Dieuzeide, Kirsten T. Eriksen, Tianpei Hong, Margit S. Kaltoft, Csaba Lengyel, Nicolai A. Rhee, Giuseppina T. Russo, Shinichiro Shirabe, Katerina Urbancova, Sergio Vencio on behalf of the CAPTURE Study Investigators
Original investigation | Published: 27 July 2021

Early and long-term prognosis in patients with and without type 2 diabetes after carotid intervention: a Swedish nationwide propensity score matched cohort study
Alexander Zabala, Anders Gottsäter, Marcus Lind, Ann-Marie Svensson, Björn Eliasson, Rebecka Bertilsson, Jan Ekelund, Thomas Nyström & Magnus Jonsson
Original investigation  |   Published: 24 April 2021

Cost-effectiveness of screening of coronary artery disease in patients with type 2 DIABetes at a very high cardiovascular risk (SCADIAB study) rational and design
Kamel Mohammedi, Nathalie Préaubert, Tanguy Cariou, Vincent Rigalleau, Ninon Foussard, Laurent Piazza, Céline Bairras-Martin, Thierry Couffinhal, Julien Bezin & Antoine Benard
Study protocol  |  Published: 13 March 2021

Activation of the cardiac non-neuronal cholinergic system prevents the development of diabetes-associated cardiovascular complications
Eng Leng Saw, James T. Pearson, Daryl O. Schwenke, Pujika Emani Munasinghe, Hirotsugu Tsuchimochi, Shruti Rawal, Sean Coffey, Philip Davis, Richard Bunton, Isabelle Van Hout, Yuko Kai, Michael J. A. Williams, Yoshihiko Kakinuma, Martin Fronius & Rajesh Katare
Original investigation  |   Published: 22 February 2021

Plasma fibrin clot properties and cardiovascular mortality in patients with type 2 diabetes: a long‐term follow‐up study
Agata Hanna Bryk, Małgorzata Konieczyńska, Maciej Polak, Dariusz Plicner, Maciej Bochenek & Anetta Undas
Original investigation  |   Published: 18 February 2021

Gender differences in screening for glucose perturbations, cardiovascular risk factor management and prognosis in patients with dysglycaemia and coronary artery disease: results from the ESC-EORP EUROASPIRE surveys
Giulia Ferrannini, Dirk De Bacquer, Pieter Vynckier, Guy De Backer, Viveca Gyberg, Kornelia Kotseva, Linda Mellbin, Anna Norhammar, Jaakko Tuomilehto, David Wood, Lars Rydén & EUROASPIRE IV & V Investigators
Original investigation  |   Published: 11 February 2021

Epicardial adipose tissue volume and coronary calcification among people living with diabetes: a cross-sectional study
Emmanuel Cosson, Minh Tuan Nguyen, Imen Rezgani, Sopio Tatulashvili, Meriem Sal, Narimane Berkane, Lucie Allard, Pierre-Yves Brillet & Hélène Bihan
Original investigation  |  Published: 05 February 2021

Sex, age, type of diabetes and incidence of atrial fibrillation in patients with diabetes mellitus: a nationwide analysis
Arnaud Bisson, Alexandre Bodin, Grégoire Fauchier, Julien Herbert, Denis Angoulvant, Pierre Henri Ducluzeau, Gregory Y. H. Lip & Laurent Fauchier
Original investigation  |  Published: 22 January 2021

Cardiovascular Diabetology is affiliated with Sackler Faculty of Medicine, Tel-Aviv University

New Content Item

Annual Journal Metrics